Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar and appetite, but some patients experience headaches during the initial treatment phase
For lifecycle management purposes, NCI exclusivity is the mechanism that gives commercial value to indication expansion programs
If you suspect you are experiencing side effects from Wegovy or macrogol, you can report these through the MHRA Yellow Card scheme (yellowcard
and scholarships from Daiichi Sankyo Healthcare, Mitsubishi Tanabe Pharma, Teijin Pharma, Medtronic, and Bayer Yakuhin
The discomfort typically stems from dehydration and dietary changes rather than the medication
The short answer is that alcohol tolerance often changes significantly on these medications